Roivant Sciences ROIV
NASDAQ ROIV
$36.50 -0.48 (-1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Non-Current Assets (2021 - 2026)

Updated

Roivant Sciences (ROIV) posted Non-Current Assets of $564.41 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 35.4% from $416.85 million a year earlier.

Analysis

Roivant Sciences (ROIV) Non-Current Assets (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences' Non-Current Assets came in at $153,000, down 24.3% from FY2025.

  • Annual Non-Current Assets has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -79.3% (FY2021 to FY2026).
  • In prior fiscal years, Roivant Sciences' Non-Current Assets was $202,000 in FY2025 (-98.6%), $14.42 million in FY2024 (-97.6%), $591.02 million in FY2023 (+34.7%) and $438.61 million in FY2022 (+8.9%).
  • Quarterly Non-Current Assets has run from a low of $153,000 in fiscal Q4 2026 to a high of $4.28 billion in fiscal Q3 2026 over five years.
  • On a year-over-year basis, Non-Current Assets increased in four of the last eight quarters, with growth averaging 1.6%.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was fiscal Q3 2024, with growth of 257.1%; the weakest was fiscal Q4 2025, with a decline of 98.6%.
  • According to Business Quant data, Non-Current Assets for the three prior fiscal quarters was $153,000 (Q4 2026), $4.28 billion (Q3 2026) and $550.95 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Roivant Sciences 26.72 Bn 27.41 Bn 1.16 Mn 564.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 564.41 Mn
Mar 31, 2026 153,000.00
Dec 31, 2025 4.28 Bn
Sep 30, 2025 550.95 Mn
Jun 30, 2025 416.85 Mn
Mar 31, 2025 202,000.00
Dec 31, 2024 2.34 Bn
Sep 30, 2024 404.91 Mn
Jun 30, 2024 494.95 Mn
Mar 31, 2024 14.42 Mn
Dec 31, 2023 1.99 Bn
Sep 30, 2023 513.92 Mn
Jun 30, 2023 575.49 Mn
Mar 31, 2023 591.02 Mn
Dec 31, 2022 556.73 Mn
Sep 30, 2022 500.67 Mn
Jun 30, 2022 560.96 Mn
Mar 31, 2022 438.61 Mn
Dec 31, 2021 511.84 Mn
Sep 30, 2021 547.15 Mn
API Access

Roivant Sciences Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ROIV&period=max&api_key=YOUR_API_KEY